Synthesis, pharmacokinetics, and metabolism of the C-terminal tripeptide of dermorphin and its diastereomer
摘要:
A tritium-labeled C-terminal fragment of dermorphin (H-Tyr-[3,4-H-3] Pro-Ser-NH2) and its isomer (H-Tyr-D-[3,4-H-3]Pro-Ser-NH2) with molar radioactivity of 35 Ci/mmol were synthesized, and their pharmacokinetics and metabolism in rat organs were studied after their intramuscular injections. The tripeptides were detected in the blood only for 5 min after the injection, and maximum contents of both compounds (approximately 5% of the total amount of the injected label) were registered in the kidneys after 20 min. Both stereomers were shown to penetrate into the brain. We failed to detect any radioactive metabolite, except proline, due to rapid proteolytic degradation of these peptides.
Synthesis, pharmacokinetics, and metabolism of the C-terminal tripeptide of dermorphin and its diastereomer
摘要:
A tritium-labeled C-terminal fragment of dermorphin (H-Tyr-[3,4-H-3] Pro-Ser-NH2) and its isomer (H-Tyr-D-[3,4-H-3]Pro-Ser-NH2) with molar radioactivity of 35 Ci/mmol were synthesized, and their pharmacokinetics and metabolism in rat organs were studied after their intramuscular injections. The tripeptides were detected in the blood only for 5 min after the injection, and maximum contents of both compounds (approximately 5% of the total amount of the injected label) were registered in the kidneys after 20 min. Both stereomers were shown to penetrate into the brain. We failed to detect any radioactive metabolite, except proline, due to rapid proteolytic degradation of these peptides.
Carbohydrate−peptide conjugates in which D-glucose is linked through an ester linkage to the carboxy group of Tyr-Pro (2), Tyr-Pro-Phe (5) or Tyr-Pro-Phe-Val (11), through the C6 hydroxygroup of the sugar moiety were synthesized to examine the utility of this type of monosaccharide modification for peptide prodrugs. Evidence is provided that glycoconjugates 2, 5, and 11 easily undergo intramolecular